<--- Back to Details
First PageDocument Content
Hepatitis / Clinical research / Pharmacology / HIV/AIDS / Hepatitis C virus / Clinical trial / Peginterferon alfa-2a / Placebo / Hepatitis C / Medicine / Health / Biology
Date: 2014-01-02 19:12:30
Hepatitis
Clinical research
Pharmacology
HIV/AIDS
Hepatitis C virus
Clinical trial
Peginterferon alfa-2a
Placebo
Hepatitis C
Medicine
Health
Biology

HCV Advocacy - A Simple Guide to Reading an Abstract

Add to Reading List

Source URL: www.hcvadvocate.org

Download Document from Source Website

File Size: 406,45 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK  HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection

DocID: 1v1Qc - View Document

227 Towards eradication of hepatitis C virus infection in the Veterans Affairs national healthcare system: a study of 107,079 antiviral treatment regimens administered fromAndrew M. Moon1, Pamela Green2, Krist

DocID: 1tab4 - View Document

Human Anti-Hepatitis C Virus Antibody, Anti-HCV ELISA Kit Cat. No.:DEIA015 Pkg.Size:96T Intended use The Human Anti-Hepatitis C Virus Antibody, Anti-HCV ELISA Kit is designed for the detection of antibodies to Hepatitis

DocID: 1t1hr - View Document

Diagnosing and monitoring Hepatitis C Hepatitis means inflammation of the liver and is often caused by a virus.

DocID: 1s7vM - View Document

BWF Grand Prix Gold and Grand Prix / Badminton / Macau Open Badminton Championships / Sports / Chinese Taipei Open / Macau Open Grand Prix Gold / Chinese Taipei Open Grand Prix Gold

論文著述 1. Publication in Journals 1. Tsai MH, Lin KH, Lin KT, Hung CM, Cheng HS, Tyan YC, Huang HW, Sanno-Duanda B, Yang MH, Yuan SS, Chu PY. Predictors for Early Identification of Hepatitis C Virus Infection. Biom

DocID: 1rsBL - View Document